SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Oct. 26, 2022 NEW YORK , Oct. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (""Supernus" or the "Company") (NASDAQ: SUPN). Such investors are advised to contact Robert S. Willoughby at
[email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Supernus and...